| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A mucoactive drug carbocisteine ameliorates steroid resistance in rat COPD model
|
Song, Yun
|
|
2016
|
39 |
C |
p. 38-47
10 p.
|
artikel
|
| 2 |
Azithromycin differentially affects the IL-13-induced expression profile in human bronchial epithelial cells
|
Mertens, Tinne C.J.
|
|
2016
|
39 |
C |
p. 14-20
7 p.
|
artikel
|
| 3 |
Cysteinyl leukotriene receptor antagonist epigenetically modulates cytokine expression and maturation of human myeloid dendritic cells
|
Kuo, Chang-Hung
|
|
2016
|
39 |
C |
p. 28-37
10 p.
|
artikel
|
| 4 |
Editorial Board
|
|
|
2016
|
39 |
C |
p. IFC-
1 p.
|
artikel
|
| 5 |
Effect of tiotropium on mucus hypersecretion and airway clearance in patients with COPD
|
Tagaya, Etsuko
|
|
2016
|
39 |
C |
p. 81-84
4 p.
|
artikel
|
| 6 |
Global research trends in the medical therapy of pulmonary arterial hypertension 2000–2014
|
Schreiber, Catharina
|
|
2016
|
39 |
C |
p. 21-27
7 p.
|
artikel
|
| 7 |
Impact of statins on ALI/ARDS: A meta-analysis
|
Gao, Xia-qing
|
|
2016
|
39 |
C |
p. 85-91
7 p.
|
artikel
|
| 8 |
Inflammatory markers as exacerbation risk factors after asthma therapy switch from inhaled steroids to montelukast
|
Ciółkowski, Janusz
|
|
2016
|
39 |
C |
p. 7-13
7 p.
|
artikel
|
| 9 |
Nefopam, a non-opioid analgesic, does not alleviate experimental work/effort dyspnoea in healthy humans: A randomised controlled trial
|
Dangers, Laurence
|
|
2016
|
39 |
C |
p. 74-80
7 p.
|
artikel
|
| 10 |
Onset of action of budesonide/formoterol Spiromax® compared with budesonide/formoterol Turbuhaler® in patients with COPD
|
Cazzola, Mario
|
|
2016
|
39 |
C |
p. 48-53
6 p.
|
artikel
|
| 11 |
Pirfenidone inhibits p38-mediated generation of procoagulant microparticles by human alveolar epithelial cells
|
Neri, Tommaso
|
|
2016
|
39 |
C |
p. 1-6
6 p.
|
artikel
|
| 12 |
Targeted drug delivery to emphysematous lungs: Inhibition of MMPs by doxycycline loaded nanoparticles
|
Parasaram, Vaideesh
|
|
2016
|
39 |
C |
p. 64-73
10 p.
|
artikel
|
| 13 |
The oral CRTh2 antagonist QAW039 (fevipiprant): A phase II study in uncontrolled allergic asthma
|
Erpenbeck, Veit J.
|
|
2016
|
39 |
C |
p. 54-63
10 p.
|
artikel
|
Tijdschrift beschrijving